Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Isocitrate dehydrogenase [NADP] cytoplasmic | ||
Ligand | BDBM50586265 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2165763 (CHEMBL5050624) | ||
IC50 | 113±n/a nM | ||
Citation | Huang, C; Fischer, C; Machacek, MR; Bogen, S; Biftu, T; Huang, X; Reutershan, MH; Otte, R; Hong, Q; Wu, Z; Yu, Y; Park, M; Chen, L; Biju, P; Knemeyer, I; Lu, P; Kochansky, CJ; Hicks, MB; Liu, Y; Helmy, R; Fradera, X; Donofrio, A; Close, J; Maddess, ML; White, C; Sloman, DL; Sciammetta, N; Lu, J; Gibeau, C; Simov, V; Zhang, H; Fuller, P; Witter, D Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors. ACS Med Chem Lett13:734-741 (2022) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Isocitrate dehydrogenase [NADP] cytoplasmic | |||
Name: | Isocitrate dehydrogenase [NADP] cytoplasmic | ||
Synonyms: | Cytosolic NADP-isocitrate dehydrogenase | IDH | IDH1 | IDHC_HUMAN | IDP | Isocitrate Dehydrogenase (IDH1) | Isocitrate dehydrogenase 1 (IDH1) | NADP(+)-specific ICDH | Oxalosuccinate decarboxylase | PICD | ||
Type: | Protein | ||
Mol. Mass.: | 46661.29 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O75874 | ||
Residue: | 414 | ||
Sequence: |
| ||
BDBM50586265 | |||
n/a | |||
Name | BDBM50586265 | ||
Synonyms: | CHEMBL5069783 | ||
Type | Small organic molecule | ||
Emp. Form. | C29H38N4O3 | ||
Mol. Mass. | 490.637 | ||
SMILES | CC(C)O[C@H]1CC[C@@H](CC1)C(=O)N1Cc2cc(C)cnc2Nc2ccc(cc12)N1CC2CCC1CO2 |r,wU:7.10,wD:4.3,(7.2,5.45,;6.11,4.36,;6.51,2.87,;4.62,4.76,;3.53,3.67,;2.04,4.07,;.96,2.98,;1.35,1.49,;2.84,1.09,;3.93,2.18,;.27,.4,;-1.22,.8,;.66,-1.09,;2.17,-1.43,;2.84,-2.81,;4.36,-2.7,;5.21,-3.97,;6.75,-3.97,;4.54,-5.34,;3.02,-5.45,;2.17,-4.18,;.67,-4.53,;-.53,-3.58,;-1.86,-4.34,;-3.2,-3.58,;-3.2,-2.04,;-1.86,-1.27,;-.53,-2.04,;-4.53,-1.27,;-5.86,-2.04,;-7.2,-1.27,;-6.43,.07,;-5.54,-1.06,;-4.53,.27,;-5.86,1.04,;-7.2,.27,)| | ||
Structure |